🔥 AZUR-1: A new era in organ preservation!

#ESMO2026

✅ A new standard of care for patients with localized dMMR/MSI-H rectal cancer!

✅✅ 154 patients enrolled in the first global, multicenter cohort!

✅✅✅ Dostarlimab monotherapy for 6 months

—cCR (98) + pCR (12/15): 76% 🔥
—98% maintained cCR for >12 months!

👉 FDA accelerated approval granted on October 19, 2026!

Congratulations to @AndreaCercek and colleagues! 👏👏👏